The burgeoning landscape of innovative treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://royngtx991754.ktwiki.com/1937063/retatrutide_vs_tirzepatide_a_comparative_analysis